-Cyclodextrine-based polyester was coated on the surface of gadolinium oxide nanoparticles (NPs) and then functionalised with folic acid to produce an efficient pH-sensitive targeted theranostic system (GdO@PCD-FA) for doxorubicin delivery and magnetic resonance imaging (MRI). GdO@PCD-FA was fully characterised by FTIR, vibrating sample magnetometer, TGA, XRD, SEM and TEM analyses. The dissolution profile of DOX showed a pH sensitive release. No significant toxicity was observed for the targeted NPs (GdO@PCD-FA) and DOX-loaded NPs inhibiting M109 cells viability more efficiently than free DOX. Moreover, the negligible hemolytic activity of the targeted NPs showed their appropriate hemocompatibility. The preferential uptake was observed for the developed GdO@PCD-FA-DOX NPs in comparison with Dotarem using - and -weighted MRI in the presence of folate receptor-positive and folate receptor-negative cancer cells (M109 and 4T1, respectively). Furthermore, studies revealed that GdO@PCD-FA-DOX not only exhibited considerably relaxivity performance as a contrast agent for MRI, but also improved anti-tumour efficacy of the system. The results suggest that GdO@PCD-FA-DOX improves its therapeutic efficacy in the treatment of solid tumours and also reduces the adverse effects, so it could be proposed as a promising drug delivery system for chemotherapy and molecular imaging diagnosis in MRI.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/1061186X.2019.1703188 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Biomedical Application Prospects of Gadolinium Oxide Nanoparticles for Regenerative Medicine.
Pharmaceutics
December 2024
Department of Hospital Surgery, Department of Plastic and Reconstructive Surgery, Cosmetology and Cell Technology, Pirogov Russian National Research Medical University (RNRMU), 117997 Moscow, Russia.
Background/objectives: The aim was to study the possibilities of biomedical application of gadolinium oxide nanoparticles (GdO NPs) synthesized under industrial conditions, and evaluate their physicochemical properties, redox activity, biological activity, and safety using different human cell lines.
Methods: The powder of GdO NPs was obtained by a process of thermal decomposition of gadolinium carbonate precipitated from nitrate solution, and was studied using transmission electron microscopy (TEM), X-ray diffraction (XRD), Raman spectroscopy, mass spectrometry, and scanning electron microscopy (SEM) with energy dispersive X-ray analyzer (EDX). The redox activity of different concentrations of GdO NPs was studied by the optical spectroscopy (OS) method in the photochemical degradation process of methylene blue dye upon irradiation with an optical source.
Gadolinium oxide nanoparticles as a multimodal contrast enhancement agent for pre-clinical proton imaging.
Phys Med Biol
January 2025
Department of Medical Physics, Ludwig-Maximilians-Universität München, Am Coulombwall 1, Garching b. München, 85748, GERMANY.
Orthotopic tumor models in pre-clinical translational research are becoming increasingly popular, raising the demands on accurate tumor localization prior to irradiation. This task remains challenging both in X-ray and proton computed tomography (xCT and pCT, respectively), due to the limited contrast of tumor tissue compared to the surrounding tissue. We investigate the feasibility of gadolinium oxide nanoparticles as multimodal contrast enhancement agent for both imaging modalities.
View Article and Find Full Text PDFDextran Sulfate-Modified and pH-Responsive Nanoprobes for Magnetic Resonance/Fluorescence Dual-Modality Imaging of Vulnerable Plaques.
J Biomed Mater Res A
January 2025
Department of Image Center, The Second Affiliated Hospital of Qiqihar Medical University, Qiqihar, China.
Triggered by the vulnerability to atherosclerotic plaques, cardiovascular diseases (CVDs) have become a main reason for high mortality worldwide. Thus, there is an urgent need to develop functional molecular imaging modalities to improve the detection rate of vulnerable plaques. In this study, polyethyleneimine (PEI) was coated on the surface of mesoporous silica nanoprobes (MSN) loaded with GdO (MSN@GdO), followed by coupling the fluorescent dye carboxylated heptamethine cyanine (IR808), and then the dextran sulfate (DS) was modified on the surface of MSN@GdO@IR808 by electrostatic adsorption, to construct a targeted and pH-responsive magnetic resonance (MR)/near-infrared fluorescence imaging (NIRF) dual-modal nanoprobe (MSN@GdO@IR808@DS nanoparticles).
View Article and Find Full Text PDFArticle Synopsis
- - The development of a new optical temperature sensing nanoprobe combines rare-earth-doped gadolinium oxide nanocrystals with mesoporous silica-coated gold nanorods to enhance tumor treatment by allowing real-time tissue temperature monitoring.
- - This nanoprobe shows a significant increase in near-infrared photoluminescence when exposed to 980 nm irradiation, enhancing sensitivity for temperature changes, which is crucial for minimizing damage to healthy tissues during therapy.
- - With its impressive temperature sensitivity of 7.25% K at 338 K and improved optical performance due to surface plasmon resonance, the nanoprobe holds great promise for advancing photothermal therapy techniques.
Preparation and characterization of a new GdO-epoxy composite for neutron shielding applications.
Sci Rep
October 2024
Department of Energy Engineering, Sharif University of Technology, Azadi Ave., P.O. Box: 11115-1639, Tehran, Iran.
The current study aims to introduce a new polymeric composite consisting of epoxy resin as the matrix and gadolinium oxide (GdO) as the neutron adsorption ingredient. The shielding performance of the composite was assessed by neutron attenuation experiments with an Am-Be source and polyethylene moderator. The results of these experiments showed an appreciable agreement with the Monte Carlo simulations.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!